Clinical Trial Update: CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CS-1008 in combination with irinotecan versus irinotecan alone in metastatic colorectal cancer after failure of oxaliplatin; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CS-1008
• Irinotecan (Irinotecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED